Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Richard Mackman

13PUBLICATIONS
50CO-AUTHORS
Obstetrics and gynaecologyProteins and peptidesPharmacogenomicsMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Jun 27, 2025
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?

Darius Babusis, Cynthia Kim, Jesse Yang

|Jul 17, 2024
Discovery of GS-7682, a Novel 4'-Cyano-Modified <i>C</i>-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys.

Dustin S Siegel, Hon C Hui, Jared Pitts

|Aug 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys.

Richard L Mackman, Rao V Kalla, Darius Babusis

|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer, David R Martinez, John J Won

|Mar 16, 2022
Phosphoramidate Prodrugs Continue to Deliver, The Journey of Remdesivir (GS-5734) from RSV to SARS-CoV-2.

Richard L Mackman

|Dec 30, 2021
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection.

Meghan S Vermillion, Eisuke Murakami, Bin Ma

Pageof 3

Frequent Collaborators

4 joint publications

Darius Babusis

3 joint publications

Roy Bannister

2 joint publications

Brian E Schultz

2 joint publications

Timothy P Sheahan

2 joint publications

Eisuke Murakami

2 joint publications

Jared Pitts

2 joint publications

Bin Ma

2 joint publications

Joy Y Feng

2 joint publications

Jason K Perry

2 joint publications

Ralph S Baric

Frequent Collaborators

4 joint publications

Darius Babusis

3 joint publications

Roy Bannister

2 joint publications

Brian E Schultz

2 joint publications

Timothy P Sheahan

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

18.0K
Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.3K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.6K
See more related videos

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

18.0K
Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.3K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.6K
See more related videos